NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in temperature-controlled supply chain solutions ...

A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a ...

QC Kinetix (QCK), a national leader in regenerative medicine and non-surgical orthobiologic care, proudly hosted its first ...

A new bioengineering platform enables the large-scale production of human kidney organoids that can be perfused within pig kidneys, maintaining viability and function without immune rejection.

DefEYE’s leadership includes key personnel from the original Verséa Ophthalmics team, ensuring continuity of expertise and relationships in the rapidly evolving eye care market. Celularity has the ...

Please provide your email address to receive an email when new articles are posted on . VG801 is a dual-AAV gene therapy in development for the treatment of Stargardt disease. The therapy is under ...

The Ministry of Health and Welfare and the Regenerative Medicine Advanced Foundation will hold the '2025 RMAF Annual ...

Planarian stem cells can be “independent” and turn into any type of cell without needing a nearby niche, a new study indicates.

GC Cell announced on the 31st that its HER2-targeted allogeneic CAR-NK cell therapy, 'AB-201 (GCC2003),' has received simultaneous approvals for its ...

Biomedical experts and practitioners in North Carolina are developing technology to rebuild skin and repair damaged organs, and they think it can be used to heal injuries on the battlefield. “You have ...

THE Asian Society for Regenerative Medicine (ASRM) proudly announces its 2nd Annual Convention and Workshop, happening at ...